This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Research article
Antonio Ibarra
Centro de Investigación en Ciencias de la Salud (CICSA), FCS, Universidad Anáhuac México Norte, Estado de México, México; Centro de Investigación del Proyecto CAMINA, Ciudad de México, México.
Corresponding Author
ORCiD: https://orcid.org/0000-0003-2489-4689
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Background Immunization with neural derived peptides (INDP) has demonstrated to be a promising therapy to achieve a regenerative effect in the chronic phase of the spinal cord injury (SCI). Nevertheless, to date INDP-induced neurogenic effects in the chronic stage of SCI has not been explored. In the present study, we first analyzed the effect of INDP on both motor and sensitive function recovery; afterwards, we assessed neurogenesis and determined the production of cytokines and neurotrophic factors. We analyzed motor and sensitivity recovery using the BBB score and the Von Frey Hair test, respectively. Neurogenesis was evaluated by immunofluorescence. Finally, we examined the expression of IL-4, IL-10, BDNF and GAP-43 using an ELISA assay.
Results During the chronic stage of SCI, rats subjected to INDP showed a significant increase in both motor and sensitive recovery when compared to the control group. Moreover, we found a significant increase in neurogenesis, mainly at the central canal and both the dorsal and ventral horns of INDP-treated animals. Finally, INDP induced a significant production of anti-inflammatory and regeneration-associated proteins in the chronic stages of injury.
Conclusions These findings suggest that INDP has a neurogenic effect that could improve motor and sensitive recovery in the chronic stage of SCI.
Keywords
A91-peptide, INDP, neurogenesis, paraplegia, protective autoimmunity
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Loading...
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
Version 1
Posted 16 Sep, 2019
No community comments so far
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Computational Neuroscience
Learn more about our company.
This is a preprint. It has not completed peer review.
Research article
Antonio Ibarra
Centro de Investigación en Ciencias de la Salud (CICSA), FCS, Universidad Anáhuac México Norte, Estado de México, México; Centro de Investigación del Proyecto CAMINA, Ciudad de México, México.
Corresponding Author
ORCiD: https://orcid.org/0000-0003-2489-4689
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
Version 1
Posted 16 Sep, 2019
No community comments so far
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Computational Neuroscience
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Background Immunization with neural derived peptides (INDP) has demonstrated to be a promising therapy to achieve a regenerative effect in the chronic phase of the spinal cord injury (SCI). Nevertheless, to date INDP-induced neurogenic effects in the chronic stage of SCI has not been explored. In the present study, we first analyzed the effect of INDP on both motor and sensitive function recovery; afterwards, we assessed neurogenesis and determined the production of cytokines and neurotrophic factors. We analyzed motor and sensitivity recovery using the BBB score and the Von Frey Hair test, respectively. Neurogenesis was evaluated by immunofluorescence. Finally, we examined the expression of IL-4, IL-10, BDNF and GAP-43 using an ELISA assay.
Results During the chronic stage of SCI, rats subjected to INDP showed a significant increase in both motor and sensitive recovery when compared to the control group. Moreover, we found a significant increase in neurogenesis, mainly at the central canal and both the dorsal and ventral horns of INDP-treated animals. Finally, INDP induced a significant production of anti-inflammatory and regeneration-associated proteins in the chronic stages of injury.
Conclusions These findings suggest that INDP has a neurogenic effect that could improve motor and sensitive recovery in the chronic stage of SCI.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Loading...